Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Meningococcal vaccine groups A C W135 and Y polysaccharide - Pfizer

Next Previous
Search
Drug Profile

Meningococcal vaccine groups A C W135 and Y polysaccharide - Pfizer

Alternative Names: ACWY Vax; Mencevax ACWY

Latest Information Update: 30 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlaxoSmithKline
  • Developer GSK
  • Class Conjugate vaccines; Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Meningococcal infections

Most Recent Events

  • 01 Oct 2015 Pfizer acquires meningococcal vaccine groups A, C, W135 and Y polysaccharide from GlaxoSmithKline
  • 22 Jun 2015 Pfizer enters into an agreement with GlaxoSmithKline to acquire its quadrivalent meningitis ACWY vaccines, including Mencevax vaccine ,
  • 22 Jun 2015 Registered for Meningococcal infections (In adolescents, In adults, In children, Prevention) in Middle East, Latin America, Europe, Australia, Africa, Asia (SC) before June 2015

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top